IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC
+0.94 (+1.12%)85.35USD290K成交股數21.8B市值77.6本益比(近四季)2.2股價營收比+1.8%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 2.0B-31% | 2.7B-1% | 2.7B-8% | 1.9B-34% | 2.8B-2% | 2.8B+3% | 2.9B+4% | 2.9B-1% | 2.9B | 2.7B | 2.8B | 2.9B |
| 營業成本 | 1.1B | 1.7B | 1.7B | 1.1B | 1.8B | – | 1.9B | 1.8B | 1.9B | 1.8B | 1.9B | 2.0B |
| 毛利 | 853M-18% | 1.0B+4% | 983M-7% | 824M-23% | 1.0B+1% | 980M+14% | 1.1B+14% | 1.1B+14% | 1.0B | 860M | 924M | 933M |
| 毛利率 | 43.7% | 37.1% | 36.5% | 42.9% | 36.4% | 35.4% | 36.0% | 37.0% | 35.3% | 31.8% | 32.8% | 31.9% |
| 研發費用 | 170M | 166M | 174M | 170M | 164M | – | 162M | 173M | 166M | 157M | 157M | 161M |
| 銷售管理費用 | 437M | 427M | 421M | 409M | 461M | – | 495M | 493M | 490M | 444M | 444M | 445M |
| 營業利益 | 158M-117% | 273M | 226M-9% | 142M-26% | −903M-554% | – | 249M+66% | 191M+32% | 199M | −2.5B | 150M | 145M |
| 營業利益率 | 8.1% | 10.0% | 8.4% | 7.4% | -31.8% | – | 8.5% | 6.6% | 6.9% | -93.8% | 5.3% | 5.0% |
| 稅後淨利 | 50.0M-105% | 169M | 40.0M-31% | 599M+252% | −1.0B-1797% | – | 58.0M+132% | 170M+530% | 60.0M | −2.6B | 25.0M | 27.0M |
| 淨利率 | 2.6% | 6.2% | 1.5% | 31.2% | -35.8% | – | 2.0% | 5.9% | 2.1% | -97.3% | 0.9% | 0.9% |
| 稀釋 EPS | 0.20-105% | 0.66 | 0.16-30% | 2.33+253% | -3.98-1830% | – | 0.23+130% | 0.66+500% | 0.23 | -10.31 | 0.10 | 0.11 |
| 稀釋股數 | 257M | 257M | 257M | 257M | 256M | – | 257M | 256M | 256M | 255M | 256M | 255M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 569M | 562M | 621M | 816M | 613M | 469M | 567M | 671M | 732M | 703M | 629M | 638M |
| 應收帳款 | 1.4B | 1.8B | 1.9B | 1.8B | 1.7B | 1.6B | 1.8B | 1.8B | 2.0B | 1.7B | 1.8B | 1.9B |
| 存貨 | 1.5B | 2.3B | 2.3B | 2.4B | 2.2B | 2.1B | 2.2B | 2.2B | 2.4B | 2.5B | 2.5B | 2.8B |
| 總資產 | 25.2B | 25.1B | 25.8B | 26.1B | 28.3B | 28.7B | 29.9B | 29.5B | 30.6B | 31.0B | 33.4B | 34.5B |
| 有息負債 | 4.7B | 4.7B | 4.7B | 5.7B | 7.6B | 7.6B | 8.6B | 8.6B | 9.2B | 9.2B | 9.2B | 9.2B |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 14.0B | 14.1B | 14.2B | 14.4B | 13.2B | 13.8B | 14.8B | 14.3B | 14.3B | 14.6B | 17.0B | 17.6B |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −4.2B | −4.2B | −4.1B | −4.9B | −7.0B | −7.1B | −8.1B | −7.9B | −8.4B | −8.5B | −8.5B | −8.6B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 257M | – | – | 127M+28% | – | – | – | 99.0M | – | – | – |
| 資本支出 | – | 165M | – | – | 179M | – | – | – | 118M | – | – | – |
| 自由現金流 | – | 92.0M | – | – | −52.0M+174% | – | – | – | −19.0M | – | – | – |
| 折舊攤銷 | – | 246M | – | – | 236M | – | – | – | 278M | – | – | – |
| 買回庫藏股 | – | 35.0M | – | – | 0.00 | – | – | – | – | – | – | – |
| 現金股利 | – | 102M | – | – | 102M | – | – | – | 207M | – | – | – |
| 自由現金流率 | – | 3.4% | – | – | -1.8% | – | – | – | -0.7% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 10.9B
| Food Ingredients | 3.3B | 30.1% | -2.6% |
|---|---|---|---|
| Taste | 2.5B | 22.8% | +2.2% |
| Scent | 2.5B | 22.8% | +1.6% |
| Health And Biosciences | 2.3B | 21.0% | +3.6% |
| Pharma Solutions | 369M | 3.4% | -64.8% |
地區2025 年度 · 10.9B
| 歐洲中東非洲 | 3.7B | 34.2% | -2.9% |
|---|---|---|---|
| North America | 3.2B | 29.3% | -7.1% |
| 亞洲 | 2.5B | 23.4% | -6.8% |
| Latin America | 1.4B | 13.1% | -3.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 10.9B | -5.2% | −359M | -3.3% | -1.41 | 256M |
| FY2024 | 11.5B | +0.0% | 267M | 2.3% | 1.04 | 607M |
| FY2023 | 11.5B | -7.7% | −2.6B | -22.5% | -10.14 | 952M |
| FY2022 | 12.4B | +6.7% | −1.9B | -15.0% | -7.32 | −107M |
| FY2021 | 11.7B | +129.3% | 279M | 2.4% | 1.10 | 1.0B |
| FY2020 | 5.1B | -1.1% | 367M | 7.2% | 3.21 | 522M |
| FY2019 | 5.1B | +29.2% | 460M | 8.9% | 4.00 | 463M |
| FY2018 | 4.0B | – | 340M | 8.5% | 3.79 | 267M |